These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 26538144
21. Trophic cascades following the disease-induced decline of an apex predator, the Tasmanian devil. Hollings T, Jones M, Mooney N, McCallum H. Conserv Biol; 2014 Feb; 28(1):63-75. PubMed ID: 24024987 [Abstract] [Full Text] [Related]
22. Discovery of Biomarkers for Tasmanian Devil Cancer (DFTD) by Metabolic Profiling of Serum. Karu N, Wilson R, Hamede R, Jones M, Woods GM, Hilder EF, Shellie RA. J Proteome Res; 2016 Oct 07; 15(10):3827-3840. PubMed ID: 27599268 [Abstract] [Full Text] [Related]
23. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease. Tovar C, Patchett AL, Kim V, Wilson R, Darby J, Lyons AB, Woods GM. PLoS One; 2018 Oct 07; 13(4):e0196469. PubMed ID: 29702669 [Abstract] [Full Text] [Related]
24. Isotopic niche variation in Tasmanian devils Sarcophilus harrisii with progression of devil facial tumor disease. Bell O, Jones ME, Cunningham CX, Ruiz-Aravena M, Hamilton DG, Comte S, Hamede RK, Bearhop S, McDonald RA. Ecol Evol; 2021 Jun 07; 11(12):8038-8053. PubMed ID: 34188870 [Abstract] [Full Text] [Related]
25. Natural killer cell mediated cytotoxic responses in the Tasmanian devil. Brown GK, Kreiss A, Lyons AB, Woods GM. PLoS One; 2011 Jun 07; 6(9):e24475. PubMed ID: 21957452 [Abstract] [Full Text] [Related]
26. Infectious disease and sickness behaviour: tumour progression affects interaction patterns and social network structure in wild Tasmanian devils. Hamilton DG, Jones ME, Cameron EZ, Kerlin DH, McCallum H, Storfer A, Hohenlohe PA, Hamede RK. Proc Biol Sci; 2020 Dec 09; 287(1940):20202454. PubMed ID: 33290679 [Abstract] [Full Text] [Related]
27. Intergenomic signatures of coevolution between Tasmanian devils and an infectious cancer. Gallinson DG, Kozakiewicz CP, Rautsaw RM, Beer MA, Ruiz-Aravena M, Comte S, Hamilton DG, Kerlin DH, McCallum HI, Hamede R, Jones ME, Storfer A, McMinds R, Margres MJ. Proc Natl Acad Sci U S A; 2024 Mar 19; 121(12):e2307780121. PubMed ID: 38466855 [Abstract] [Full Text] [Related]
28. A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I. Kayigwe AN, M Darby J, Lyons AB, L Patchett A, Lisowski L, Liu GS, S Flies A. J Gen Virol; 2022 Nov 19; 103(11):. PubMed ID: 36382885 [Abstract] [Full Text] [Related]
29. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii). Patchett AL, Coorens THH, Darby J, Wilson R, McKay MJ, Kamath KS, Rubin A, Wakefield M, Mcintosh L, Mangiola S, Pye RJ, Flies AS, Corcoran LM, Lyons AB, Woods GM, Murchison EP, Papenfuss AT, Tovar C. Cell Mol Life Sci; 2020 May 19; 77(9):1847-1858. PubMed ID: 31375869 [Abstract] [Full Text] [Related]
30. HEMATOLOGICAL AND SERUM BIOCHEMICAL VALUES IN ANESTHETIZED CAPTIVE TASMANIAN DEVILS (SARCOPHILUS HARRISII). Hope KL, Peck S. J Zoo Wildl Med; 2016 Jun 19; 47(2):564-72. PubMed ID: 27468030 [Abstract] [Full Text] [Related]
31. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response. Hamede RK, Pearse AM, Swift K, Barmuta LA, Murchison EP, Jones ME. Proc Biol Sci; 2015 Sep 07; 282(1814):. PubMed ID: 26336167 [Abstract] [Full Text] [Related]
32. Leptospirosis in Tasmanian Devils ( Sarcophilus harrisii ) in Tasmania, 2008-12. Wynwood SJ, Burns MA, Graham GC, Weier SL, McKay DB, Peck S, Craig SB. J Wildl Dis; 2016 Jul 07; 52(3):636-41. PubMed ID: 27243149 [Abstract] [Full Text] [Related]
33. Hematologic and serum biochemical reference intervals for wild Tasmanian devils (Sarcophilus harrisii). Peck S, Corkrey R, Hamede R, Jones M, Canfield P. Vet Clin Pathol; 2015 Dec 07; 44(4):519-29. PubMed ID: 26613213 [Abstract] [Full Text] [Related]
35. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii). Hubert JN, Zerjal T, Hospital F. PLoS One; 2018 Aug 07; 13(8):e0201838. PubMed ID: 30102725 [Abstract] [Full Text] [Related]
36. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil. Bender HS, Marshall Graves JA, Deakin JE. Annu Rev Anim Biosci; 2014 Feb 07; 2():165-87. PubMed ID: 25384139 [Abstract] [Full Text] [Related]
37. Evidence that disease-induced population decline changes genetic structure and alters dispersal patterns in the Tasmanian devil. Lachish S, Miller KJ, Storfer A, Goldizen AW, Jones ME. Heredity (Edinb); 2011 Jan 07; 106(1):172-82. PubMed ID: 20216571 [Abstract] [Full Text] [Related]
38. Comparative landscape genetics reveals differential effects of environment on host and pathogen genetic structure in Tasmanian devils (Sarcophilus harrisii) and their transmissible tumour. Kozakiewicz CP, Ricci L, Patton AH, Stahlke AR, Hendricks SA, Margres MJ, Ruiz-Aravena M, Hamilton DG, Hamede R, McCallum H, Jones ME, Hohenlohe PA, Storfer A. Mol Ecol; 2020 Sep 07; 29(17):3217-3233. PubMed ID: 32682353 [Abstract] [Full Text] [Related]
39. Sex determination by SRY PCR and sequencing of Tasmanian devil facial tumour cell lines reveals non-allograft transmission. Cui X, Wang Y, Hua B, Miller W, Zhao Y, Cui H, Kong X. Biochem Biophys Res Commun; 2016 May 20; 474(1):29-34. PubMed ID: 27084454 [Abstract] [Full Text] [Related]
40. Biting injuries and transmission of Tasmanian devil facial tumour disease. Hamede RK, McCallum H, Jones M. J Anim Ecol; 2013 Jan 20; 82(1):182-90. PubMed ID: 22943286 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]